ImmunoPrecise Antibodies
IPA
#9890
Rank
A$32.18 M
Marketcap
$0.70
Share price
-3.00%
Change (1 day)
-61.60%
Change (1 year)

Market capitalization of ImmunoPrecise Antibodies (IPA)

Market cap: A$32.18 Million

As of April 2025 ImmunoPrecise Antibodies has a market cap of A$32.18 Million. This makes ImmunoPrecise Antibodies the world's 9890th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ImmunoPrecise Antibodies from 2009 to 2025

End of year Market Cap

Year Marketcap Change
2025A$32.18 M57.21%
2024A$20.47 M-69%
2023A$66.04 M-65.4%
2022A$0.19 B32.9%
2021A$0.14 B-56.04%
2020A$0.32 B664.28%
2019A$42.75 M-12.14%
2018A$48.66 M72.73%
2017A$28.17 M59.9%
2016A$17.62 M119571.23%
2015A$0.01 M-93.05%
2014A$0.21 M281.47%
2013A$0.05 M
2011A$0.59 M-75.74%
2010A$2.43 M-20.64%
2009A$3.07 M

End of Day market cap according to different sources

On Apr 24th, 2025 the market cap of ImmunoPrecise Antibodies was reported to be:

A$22.52 Million
by Nasdaq info icon info icon
A$33.18 Million
by CompaniesMarketCap info icon info icon
A$33.18 Million
by Yahoo Finance info icon info icon